Saved in:
Bibliographic Details
Main Author: Healthcare
Format: Recurso digital
Language:
Published: Zenodo 2025
Online Access:https://doi.org/10.5281/zenodo.15971924
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1866902260012810240
author Healthcare
author_facet Healthcare
contents <p><strong>Global Genomics Market Analysis</strong></p> <p>The global <a href="https://www.fortunebusinessinsights.com/industry-reports/genomics-market-100941">genomics market</a> is projected to reach $80.17 billion by 2032, growing at a CAGR of 12.7% from $30.75 billion in 2024. North America dominates with a 43.71% market share as of 2023.</p> <p><strong>Key Growth Drivers</strong></p> <ul> <li>Rising demand for precision medicine and personalized treatments</li> <li>Increasing government funding for genome research projects</li> <li>Growing applications in disease prevention and management</li> <li>Declining costs of genome sequencing technologies</li> </ul> <p><strong>Market Segments</strong></p> <p><strong>By Type</strong></p> <ul> <li>Products (instruments, software, consumables)</li> <li>Services</li> </ul> <p>The products segment leads the market, driven by high demand for consumables and the introduction of automated sequencing platforms.</p> <p><strong>By Technology</strong></p> <ul> <li>Polymerase Chain Reaction (PCR)</li> <li>Next-Generation Sequencing (NGS)</li> <li>Microarray</li> <li>Sanger Sequencing</li> <li>Others</li> </ul> <p><strong>By Application</strong></p> <ul> <li>Diagnostics</li> <li>Research</li> <li>Others</li> </ul> <p><strong>Regional Analysis</strong></p> <p><strong>North America</strong></p> <ul> <li>Market value: $12.13 billion (2023)</li> <li>Leading position due to rapid adoption of new sequencing technologies</li> <li>Strong government support through research funding</li> <li>Notable investment: $1.7 billion by Biden Administration in 2021 to fight COVID-19 variants</li> </ul> <p><strong>Europe</strong></p> <ul> <li>Growing support from government for genomic research</li> <li>Active research institutes, especially in UK and England</li> <li>Significant investments in genomic epidemiology</li> </ul> <p><strong>Asia Pacific</strong></p> <ul> <li>Fastest growing region</li> <li>High demand for genetic sequencing in China</li> <li>Advancements in bioinformatics</li> <li>Growing focus on rare disease research</li> </ul> <p><strong>Key Industry Developments</strong></p> <p>Recent significant developments include:</p> <ul> <li>January 2024: Gencove and Ferris Genomics announced collaboration for end-to-end genomics sequencing services</li> <li>November 2023: MedGenome and PacBio announced grant for De Novo Genome Assembly</li> <li>December 2022: UK government invested $190 million for genomic research</li> </ul> <p><strong>Market Leaders</strong></p> <p>Leading companies in the global genomics market:</p> <ul> <li>Illumina, Inc.</li> <li>Thermo Fisher Scientific Inc.</li> <li>Oxford Nanopore Technologies</li> <li>F. Hoffmann-La Roche Ltd</li> <li>Agilent Technologies, Inc.</li> <li>QIAGEN</li> <li>BGI</li> <li>Danaher</li> </ul> <p><strong>Future Outlook</strong></p> <p>The market faces some challenges:</p> <ul> <li>High costs of establishing genomics laboratories</li> <li>Shortage of trained technicians in developing countries</li> <li>Data storage and security concerns</li> <li>Stringent regulatory frameworks</li> </ul> <p>However, growth opportunities include:</p> <ul> <li>Increasing adoption of precision medicine</li> <li>Rising demand for direct-to-consumer genetic testing</li> <li>Growing applications in drug discovery</li> <li>Expanding research in emerging economies</li> </ul> <p><strong>Report-</strong></p> <p><a href="https://www.fortunebusinessinsights.com/industry-reports/genomics-market-100941">Fortune Business Insights - Genomics Market Size, Share, Trends & Growth Forecast, 2032</a></p> <p><a href="https://www.fortunebusinessinsights.com/industry-reports/genomics-market-100941">https://www.fortunebusinessinsights.com/industry-reports/genomics-market-100941</a></p>
format Recurso digital
id zenodo_https___doi_org_10_5281_zenodo_15971924
institution Zenodo
language
publishDate 2025
publisher Zenodo
record_format zenodo
spellingShingle Genomics Industry Analysis: Size, Share, and Forecast Insights to 2032
Healthcare
<p><strong>Global Genomics Market Analysis</strong></p> <p>The global <a href="https://www.fortunebusinessinsights.com/industry-reports/genomics-market-100941">genomics market</a> is projected to reach $80.17 billion by 2032, growing at a CAGR of 12.7% from $30.75 billion in 2024. North America dominates with a 43.71% market share as of 2023.</p> <p><strong>Key Growth Drivers</strong></p> <ul> <li>Rising demand for precision medicine and personalized treatments</li> <li>Increasing government funding for genome research projects</li> <li>Growing applications in disease prevention and management</li> <li>Declining costs of genome sequencing technologies</li> </ul> <p><strong>Market Segments</strong></p> <p><strong>By Type</strong></p> <ul> <li>Products (instruments, software, consumables)</li> <li>Services</li> </ul> <p>The products segment leads the market, driven by high demand for consumables and the introduction of automated sequencing platforms.</p> <p><strong>By Technology</strong></p> <ul> <li>Polymerase Chain Reaction (PCR)</li> <li>Next-Generation Sequencing (NGS)</li> <li>Microarray</li> <li>Sanger Sequencing</li> <li>Others</li> </ul> <p><strong>By Application</strong></p> <ul> <li>Diagnostics</li> <li>Research</li> <li>Others</li> </ul> <p><strong>Regional Analysis</strong></p> <p><strong>North America</strong></p> <ul> <li>Market value: $12.13 billion (2023)</li> <li>Leading position due to rapid adoption of new sequencing technologies</li> <li>Strong government support through research funding</li> <li>Notable investment: $1.7 billion by Biden Administration in 2021 to fight COVID-19 variants</li> </ul> <p><strong>Europe</strong></p> <ul> <li>Growing support from government for genomic research</li> <li>Active research institutes, especially in UK and England</li> <li>Significant investments in genomic epidemiology</li> </ul> <p><strong>Asia Pacific</strong></p> <ul> <li>Fastest growing region</li> <li>High demand for genetic sequencing in China</li> <li>Advancements in bioinformatics</li> <li>Growing focus on rare disease research</li> </ul> <p><strong>Key Industry Developments</strong></p> <p>Recent significant developments include:</p> <ul> <li>January 2024: Gencove and Ferris Genomics announced collaboration for end-to-end genomics sequencing services</li> <li>November 2023: MedGenome and PacBio announced grant for De Novo Genome Assembly</li> <li>December 2022: UK government invested $190 million for genomic research</li> </ul> <p><strong>Market Leaders</strong></p> <p>Leading companies in the global genomics market:</p> <ul> <li>Illumina, Inc.</li> <li>Thermo Fisher Scientific Inc.</li> <li>Oxford Nanopore Technologies</li> <li>F. Hoffmann-La Roche Ltd</li> <li>Agilent Technologies, Inc.</li> <li>QIAGEN</li> <li>BGI</li> <li>Danaher</li> </ul> <p><strong>Future Outlook</strong></p> <p>The market faces some challenges:</p> <ul> <li>High costs of establishing genomics laboratories</li> <li>Shortage of trained technicians in developing countries</li> <li>Data storage and security concerns</li> <li>Stringent regulatory frameworks</li> </ul> <p>However, growth opportunities include:</p> <ul> <li>Increasing adoption of precision medicine</li> <li>Rising demand for direct-to-consumer genetic testing</li> <li>Growing applications in drug discovery</li> <li>Expanding research in emerging economies</li> </ul> <p><strong>Report-</strong></p> <p><a href="https://www.fortunebusinessinsights.com/industry-reports/genomics-market-100941">Fortune Business Insights - Genomics Market Size, Share, Trends & Growth Forecast, 2032</a></p> <p><a href="https://www.fortunebusinessinsights.com/industry-reports/genomics-market-100941">https://www.fortunebusinessinsights.com/industry-reports/genomics-market-100941</a></p>
title Genomics Industry Analysis: Size, Share, and Forecast Insights to 2032
url https://doi.org/10.5281/zenodo.15971924